8-K: Dorchester Minerals Faces Nasdaq Non-Compliance After Manager's Death

Dorchester Minerals, L.P. announced non-compliance with Nasdaq listing rules regarding its audit committee composition following the passing of a key manager.

Summary

• C.W. (Bill) Russell, a manager of Dorchester Minerals Management GP LLC and a member of the Advisory Committee, passed away on October 30, 2025.
• His passing reduced the Advisory Committee, which also functions as the audit committee, from three to two members.
• This change resulted in non-compliance with Nasdaq Listing Rules 5615(a)(4)(C) and 5605(c)(2)(A), which mandate an audit committee of at least three independent members.
• The Partnership notified Nasdaq on November 3, 2025, and received an acknowledgment of non-compliance on November 10, 2025.
• Nasdaq has provided a cure period until the earlier of the next annual unitholders meeting or October 30, 2026, or by April 28, 2026, if the meeting is before that date.
• The Partnership intends to appoint a replacement to regain compliance within the cure period.

Sentiment

Score: 4

Explanation: The passing of a long-serving manager and the resulting non-compliance with Nasdaq rules are negative events. However, Nasdaq has provided a clear cure period, and management has expressed intent to resolve the issue, mitigating the immediate severity.

Positives

• The Partnership has a clear path to regain compliance through a defined cure period provided by Nasdaq.
• Management has expressed a clear intent to appoint a replacement to satisfy Nasdaq listing requirements.

Negatives

• The passing of C.W. (Bill) Russell, a long-serving manager and Advisory Committee member since May 2004.
• The Partnership is currently non-compliant with Nasdaq's audit committee composition rules, requiring at least three independent members.

Risks

• Failure to appoint a qualified replacement for the Advisory Committee within the specified cure period could lead to further enforcement actions by Nasdaq, potentially including delisting.

Future Outlook

The Partnership and the General Partner intend to appoint a replacement for the Advisory Committee position who satisfies the applicable Nasdaq Listing Rules requirements prior to the expiration of the cure period.

Management Comments

• "The Partnership and the General Partner intend to have a replacement for the Advisory Committee position who satisfies the applicable requirements of the Nasdaq Listing Rules appointed prior to the expiration of the cure period."

Industry Context

This event highlights the critical importance of robust corporate governance structures and succession planning, particularly for audit committee roles, to maintain compliance with exchange listing standards in the energy minerals sector.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential uncertainty regarding continued Nasdaq listing if compliance is not regained, though a cure period is in place.
• Management/Board: Increased workload and urgency to identify and appoint a suitable replacement for the Advisory Committee.

Next Steps

• Appoint a qualified replacement for the Advisory Committee position.
• Regain compliance with Nasdaq Listing Rules 5615(a)(4)(C) and 5605(c)(2)(A) within the specified cure period.

Key Dates

Keywords

Dorchester Minerals, DMLP, Nasdaq, Audit Committee, Corporate Governance, SEC Filing, 8-K, Compliance, Management Change, Listing Rules